Equitable Law Advises The Rainbow Seed Fund Upon The Creation Of Its New Segregated Synthetic Biology Portfolio

Equitable Law is delighted to announce the successful completion of its legal advice and assistance to its long established client, the Rainbow Seed Fund in relation to the creation of its new ten million pounds sterling (GBP £10m) segregated 'Synthetic Biology Portfolio'.

Synthetic biology is the design and construction of novel biologically based parts, devices and systems, as well as the redesign of existing natural biological systems for useful purposes.  It has a number of potential applications within the bio-based knowledge economy.  These include: industrial biotechnology, bioenergy, bioprocessing, novel materials and biosensors.

Synthetic biology is one of the eight (8) great technologies highlighted by the UK government as areas of wide-ranging significance and potential economic importance, in which the UK’s research base is particularly strong.

Further details are available at :- http://midven.co.uk/news/midven-to-manage-synthetic-biology-enterprise-fund/

Dr. Andrew Muir, Partner of Midven, the manager of the Rainbow Seed Fund commented - "We are delighted by Equitable Law's assistance with the expansion of the fund by way of the creation of the new portfolio of the fund.  The fund has now trebled in size since Dan Johnson started to assist the Fund and we thank Dan (and his team) for their continued support to the fund".